The Joint Corp. (JYNT) Tops Q1 EPS by 16c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
The Joint Corp. Reports First Quarter 2023 Financial Results
May 4, 2023 4:05 PM EDT- Grew Q1 2023 Revenue 27%, System-wide Sales 17% and System-wide Comp Sales 8% vs. Q1 2022 -- Increased Clinic Count to 870, Including 130 Company-Owned or Managed Clinics, at March 31, 2023 -
SCOTTSDALE, Ariz., May 04, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2023.
Financial Highlights: Q1 2023 Compared to Q1 2022
Grew revenue 27% to $28.5 million.Reported operating loss of $678,000, compared to a loss of $176,000.Reported net income of $2.3 million, including $3.9 million of employee... More